Zhejiang Haisen Pharmaceutical (001367) Income Statement & Earnings

24.14
+0.19+0.79%

Market Closed Jan 16 15:00 CST

3.68BMarket Cap29.69P/E (TTM)

Zhejiang Haisen Pharmaceutical (001367) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Total operating revenue

12.13%358.87M

14.93%242.09M

2.32%118.48M

18.63%471.51M

13.02%320.04M

8.93%210.64M

8.27%115.8M

-5.99%397.45M

-10.44%283.17M

-8.50%193.37M

Operating revenue

12.13%358.87M

14.93%242.09M

2.32%118.48M

18.63%471.51M

13.02%320.04M

8.93%210.64M

8.27%115.8M

-5.99%397.45M

-10.44%283.17M

-8.50%193.37M

Other operating revenue

----

-5.82%407.79K

----

-17.36%965.74K

----

-53.80%432.99K

----

-28.82%1.17M

----

-20.47%937.11K

Total operating cost

17.47%259.59M

18.86%172.7M

7.96%83.57M

19.91%333.03M

9.41%220.99M

3.15%145.3M

-0.08%77.41M

-8.61%277.74M

-10.13%201.98M

-4.76%140.86M

Operating cost

4.07%195.28M

8.00%134.3M

-6.26%66.1M

17.84%275.96M

10.57%187.65M

5.40%124.36M

4.66%70.51M

-11.57%234.18M

-14.85%169.7M

-10.18%117.99M

Operating tax surcharges

7.65%3.6M

2.81%2.32M

13.61%1.01M

4.75%4.36M

16.24%3.35M

7.46%2.25M

17.00%892.61K

95.38%4.16M

32.34%2.88M

121.45%2.1M

Operating expense

28.98%11.18M

12.18%6.74M

49.46%2.56M

18.06%12.35M

8.26%8.67M

14.19%6M

-10.76%1.71M

4.22%10.46M

4.69%8M

1.61%5.26M

Administration expense

41.09%25.68M

29.34%15.49M

38.25%7.01M

17.96%30.71M

-9.05%18.2M

-13.62%11.98M

5.29%5.07M

14.53%26.03M

18.35%20.01M

20.67%13.87M

Financial expense

70.66%-4.31M

64.60%-3.85M

49.55%-2.55M

-13.74%-18.13M

-33.27%-14.69M

-76.41%-10.88M

-1,133.71%-5.06M

-37.70%-15.94M

-4.70%-11.03M

10.19%-6.17M

-Interest expense (Financial expense)

-7.15%259.16K

-6.36%172.79K

-7.94%84.93K

1,000.55%373.72K

986.72%279.12K

467.99%184.52K

467.99%92.26K

-49.99%33.96K

-50.28%25.68K

-8.26%32.49K

-Interest Income (Financial expense)

69.90%-4M

66.44%-3.08M

53.40%-1.92M

-0.75%-15.41M

-32.28%-13.28M

-68.25%-9.17M

-213.59%-4.12M

-330.91%-15.3M

-348.33%-10.04M

-303.92%-5.45M

Research and development

57.96%28.17M

52.83%17.71M

120.63%9.44M

47.44%27.78M

43.61%17.83M

48.10%11.59M

42.58%4.28M

19.50%18.84M

33.87%12.42M

34.89%7.82M

Credit Impairment Loss

-170.86%-566.72K

-205.41%-448.21K

182.19%45.09K

76.25%-101.55K

50,837.53%799.76K

151.35%425.21K

90.25%-54.86K

44.38%-427.52K

99.89%-1.58K

68.17%-828.11K

Asset Impairment Loss

32.50%-400.2K

52.91%-256.9K

95.52%-13.76K

-45.07%-3.54M

-21.81%-592.85K

-32.50%-545.51K

---306.99K

-107.81%-2.44M

41.90%-486.71K

55.68%-411.69K

Other net revenue

13.28%2.92M

-58.51%843.08K

27.71%902.75K

57.62%3.56M

19.76%2.58M

309.42%2.03M

240.24%706.85K

-18.50%2.26M

53.63%2.15M

170.32%496.32K

Invest income

1,426.94%2.66M

--568.73K

--213.66K

838.57%3M

--174.27K

----

110.30%319.69K

----

Asset deal income

----

---241.71K

Other revenue

-44.19%1.23M

-54.49%979.47K

-38.45%657.76K

-16.79%4.2M

-23.80%2.2M

8.82%2.15M

255.81%1.07M

-41.03%5.05M

-61.78%2.88M

-68.02%1.98M

Operating profit

0.55%102.19M

4.23%70.23M

-8.40%35.81M

16.46%142.05M

21.95%101.63M

27.12%67.37M

34.91%39.1M

0.27%121.97M

-10.20%83.34M

-15.51%53M

Add:Non operating Income

801.06%571.27K

805.40%566.79K

724.29%501.17K

13,960.07%1.23M

856.46%63.4K

946.21%62.6K

974.10%60.8K

-99.78%8.74K

-99.83%6.63K

-99.85%5.98K

Less:Non operating expense

-72.32%397.45K

-31.31%298.55K

-52.00%125.02K

13.81%1.49M

203.90%1.44M

70.67%434.65K

196.84%260.46K

-29.89%1.31M

-49.40%472.43K

-68.71%254.67K

Total profit

2.10%102.37M

5.21%70.49M

-6.97%36.19M

17.49%141.79M

20.98%100.26M

27.01%67M

34.60%38.9M

-2.51%120.68M

-13.57%82.87M

-19.98%52.75M

Less:Income tax cost

6.38%14.16M

8.26%9.7M

-9.75%4.98M

20.11%19.23M

21.56%13.31M

29.05%8.96M

41.34%5.51M

-1.13%16.01M

-16.47%10.95M

-23.32%6.94M

Net profit

1.45%88.21M

4.74%60.79M

-6.51%31.21M

17.09%122.56M

20.89%86.95M

26.70%58.04M

33.55%33.38M

-2.72%104.67M

-13.11%71.93M

-19.45%45.81M

Net profit from continuing operation

1.45%88.21M

4.74%60.79M

-6.51%31.21M

17.09%122.56M

20.89%86.95M

26.70%58.04M

33.55%33.38M

-2.72%104.67M

-13.11%71.93M

-19.45%45.81M

Net profit of parent company owners

1.45%88.21M

4.74%60.79M

-6.51%31.21M

17.09%122.56M

20.89%86.95M

26.70%58.04M

33.55%33.38M

-2.72%104.67M

-13.11%71.93M

-19.45%45.81M

Earning per share

Basic earning per share

1.72%0.59

5.13%0.41

-6.06%0.31

7.96%1.22

-27.50%0.58

-29.09%0.39

-32.65%0.33

-46.45%1.13

-50.62%0.8

-50.89%0.55

Diluted earning per share

0.00%0.58

2.56%0.4

-9.09%0.3

7.08%1.21

-27.50%0.58

-29.09%0.39

-32.65%0.33

-46.45%1.13

-50.62%0.8

-50.89%0.55

Other composite income

Total composite income

1.45%88.21M

4.74%60.79M

-6.51%31.21M

17.09%122.56M

20.89%86.95M

26.70%58.04M

33.55%33.38M

-2.72%104.67M

-13.11%71.93M

-19.45%45.81M

Total composite income of parent company owners

1.45%88.21M

4.74%60.79M

-6.51%31.21M

17.09%122.56M

20.89%86.95M

26.70%58.04M

33.55%33.38M

-2.72%104.67M

-13.11%71.93M

-19.45%45.81M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Total operating revenue	12.13%358.87M	14.93%242.09M	2.32%118.48M	18.63%471.51M	13.02%320.04M	8.93%210.64M	8.27%115.8M	-5.99%397.45M	-10.44%283.17M	-8.50%193.37M
Operating revenue	12.13%358.87M	14.93%242.09M	2.32%118.48M	18.63%471.51M	13.02%320.04M	8.93%210.64M	8.27%115.8M	-5.99%397.45M	-10.44%283.17M	-8.50%193.37M
Other operating revenue	----	-5.82%407.79K	----	-17.36%965.74K	----	-53.80%432.99K	----	-28.82%1.17M	----	-20.47%937.11K
Total operating cost	17.47%259.59M	18.86%172.7M	7.96%83.57M	19.91%333.03M	9.41%220.99M	3.15%145.3M	-0.08%77.41M	-8.61%277.74M	-10.13%201.98M	-4.76%140.86M
Operating cost	4.07%195.28M	8.00%134.3M	-6.26%66.1M	17.84%275.96M	10.57%187.65M	5.40%124.36M	4.66%70.51M	-11.57%234.18M	-14.85%169.7M	-10.18%117.99M
Operating tax surcharges	7.65%3.6M	2.81%2.32M	13.61%1.01M	4.75%4.36M	16.24%3.35M	7.46%2.25M	17.00%892.61K	95.38%4.16M	32.34%2.88M	121.45%2.1M
Operating expense	28.98%11.18M	12.18%6.74M	49.46%2.56M	18.06%12.35M	8.26%8.67M	14.19%6M	-10.76%1.71M	4.22%10.46M	4.69%8M	1.61%5.26M
Administration expense	41.09%25.68M	29.34%15.49M	38.25%7.01M	17.96%30.71M	-9.05%18.2M	-13.62%11.98M	5.29%5.07M	14.53%26.03M	18.35%20.01M	20.67%13.87M
Financial expense	70.66%-4.31M	64.60%-3.85M	49.55%-2.55M	-13.74%-18.13M	-33.27%-14.69M	-76.41%-10.88M	-1,133.71%-5.06M	-37.70%-15.94M	-4.70%-11.03M	10.19%-6.17M
-Interest expense (Financial expense)	-7.15%259.16K	-6.36%172.79K	-7.94%84.93K	1,000.55%373.72K	986.72%279.12K	467.99%184.52K	467.99%92.26K	-49.99%33.96K	-50.28%25.68K	-8.26%32.49K
-Interest Income (Financial expense)	69.90%-4M	66.44%-3.08M	53.40%-1.92M	-0.75%-15.41M	-32.28%-13.28M	-68.25%-9.17M	-213.59%-4.12M	-330.91%-15.3M	-348.33%-10.04M	-303.92%-5.45M
Research and development	57.96%28.17M	52.83%17.71M	120.63%9.44M	47.44%27.78M	43.61%17.83M	48.10%11.59M	42.58%4.28M	19.50%18.84M	33.87%12.42M	34.89%7.82M
Credit Impairment Loss	-170.86%-566.72K	-205.41%-448.21K	182.19%45.09K	76.25%-101.55K	50,837.53%799.76K	151.35%425.21K	90.25%-54.86K	44.38%-427.52K	99.89%-1.58K	68.17%-828.11K
Asset Impairment Loss	32.50%-400.2K	52.91%-256.9K	95.52%-13.76K	-45.07%-3.54M	-21.81%-592.85K	-32.50%-545.51K	---306.99K	-107.81%-2.44M	41.90%-486.71K	55.68%-411.69K
Other net revenue	13.28%2.92M	-58.51%843.08K	27.71%902.75K	57.62%3.56M	19.76%2.58M	309.42%2.03M	240.24%706.85K	-18.50%2.26M	53.63%2.15M	170.32%496.32K
Invest income	1,426.94%2.66M	--568.73K	--213.66K	838.57%3M	--174.27K	----	----	110.30%319.69K	----	----
Asset deal income	----	----	----	----	----	----	----	---241.71K	---241.71K	---241.71K
Other revenue	-44.19%1.23M	-54.49%979.47K	-38.45%657.76K	-16.79%4.2M	-23.80%2.2M	8.82%2.15M	255.81%1.07M	-41.03%5.05M	-61.78%2.88M	-68.02%1.98M
Operating profit	0.55%102.19M	4.23%70.23M	-8.40%35.81M	16.46%142.05M	21.95%101.63M	27.12%67.37M	34.91%39.1M	0.27%121.97M	-10.20%83.34M	-15.51%53M
Add:Non operating Income	801.06%571.27K	805.40%566.79K	724.29%501.17K	13,960.07%1.23M	856.46%63.4K	946.21%62.6K	974.10%60.8K	-99.78%8.74K	-99.83%6.63K	-99.85%5.98K
Less:Non operating expense	-72.32%397.45K	-31.31%298.55K	-52.00%125.02K	13.81%1.49M	203.90%1.44M	70.67%434.65K	196.84%260.46K	-29.89%1.31M	-49.40%472.43K	-68.71%254.67K
Total profit	2.10%102.37M	5.21%70.49M	-6.97%36.19M	17.49%141.79M	20.98%100.26M	27.01%67M	34.60%38.9M	-2.51%120.68M	-13.57%82.87M	-19.98%52.75M
Less:Income tax cost	6.38%14.16M	8.26%9.7M	-9.75%4.98M	20.11%19.23M	21.56%13.31M	29.05%8.96M	41.34%5.51M	-1.13%16.01M	-16.47%10.95M	-23.32%6.94M
Net profit	1.45%88.21M	4.74%60.79M	-6.51%31.21M	17.09%122.56M	20.89%86.95M	26.70%58.04M	33.55%33.38M	-2.72%104.67M	-13.11%71.93M	-19.45%45.81M
Net profit from continuing operation	1.45%88.21M	4.74%60.79M	-6.51%31.21M	17.09%122.56M	20.89%86.95M	26.70%58.04M	33.55%33.38M	-2.72%104.67M	-13.11%71.93M	-19.45%45.81M
Net profit of parent company owners	1.45%88.21M	4.74%60.79M	-6.51%31.21M	17.09%122.56M	20.89%86.95M	26.70%58.04M	33.55%33.38M	-2.72%104.67M	-13.11%71.93M	-19.45%45.81M
Earning per share
Basic earning per share	1.72%0.59	5.13%0.41	-6.06%0.31	7.96%1.22	-27.50%0.58	-29.09%0.39	-32.65%0.33	-46.45%1.13	-50.62%0.8	-50.89%0.55
Diluted earning per share	0.00%0.58	2.56%0.4	-9.09%0.3	7.08%1.21	-27.50%0.58	-29.09%0.39	-32.65%0.33	-46.45%1.13	-50.62%0.8	-50.89%0.55
Other composite income
Total composite income	1.45%88.21M	4.74%60.79M	-6.51%31.21M	17.09%122.56M	20.89%86.95M	26.70%58.04M	33.55%33.38M	-2.72%104.67M	-13.11%71.93M	-19.45%45.81M
Total composite income of parent company owners	1.45%88.21M	4.74%60.79M	-6.51%31.21M	17.09%122.56M	20.89%86.95M	26.70%58.04M	33.55%33.38M	-2.72%104.67M	-13.11%71.93M	-19.45%45.81M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"